Different effects of two methods of low-density lipoprotein apheresis on the coagulation and fibrinolytic systems.
OBJECTIVE
Immunoadsorption (IMA) and dextran sulfate adsorption (DSA) are two methods for selective extracorporeal elimination of low-density lipoproteins which are known as LDL apheresis. Their influence on haemostasis until now is widely unknown.


METHODS
The effects of both LDL apheresis procedures on the coagulation and fibrinolytic systems were compared amongst five patients treated with IMA and four patients who received a DSA therapy.


METHODS
All patients with severe heterozygous familial hypercholesterolaemia were participants in a long-term LDL apheresis programme with treatments every 1-2 weeks.


METHODS
Combined anticoagulation with heparin and citrate in IMA, and also heparin exclusively in DSA were used for the extracorporeal circulation.


METHODS
Blood samples were taken immediately before and after a single LDL apheresis and five times during the weekly interval until the next therapy.


RESULTS
DSA had a significantly greater effect on standard clotting tests than IMA at the end of plasma therapy despite identical dosages of heparin. DSA caused a considerable reduction of the coagulation factors V, VIII:C, vWF:Ag, XI, XII, and prekallikrein by 48-99% at the end of apheresis treatment whereas only factor VIII:C showed a marked decrease of 72% after IMA. All abnormalities of the global coagulation tests and of most clotting factors were restored 1 day after treatment in both procedures followed by a moderate rebound phenomenon of single coagulation factors during the next few days in IMA-treated patients.


CONCLUSIONS
DSA exerts a more profound effect on the coagulation system than IMA by a substantial co-elimination of various clotting factors in addition to the desired removal of atherogenic lipoproteins.
Knisel
W
W
Fourth Department of Internal Medicine, University Hospital of Tübingen, Germany.
Di Nicuolo
A
A
Pfohl
M
M
Müller
H
H
Risler
T
T
Eggstein
M
M
Seifried
E
E
D000327:Adsorption; D000328:Adult; D001777:Blood Coagulation / Q000502:physiology*; D001781:Blood Component Removal / Q000379:methods*; D016264:Dextran Sulfate; D005260:Female; D005342:Fibrinolysis / Q000502:physiology; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood* / Q000628:therapy*; D007163:Immunosorbent Techniques; D008077:Lipoproteins, LDL / Q000097:blood*; D008297:Male; D008875:Middle Aged
D008077:Lipoproteins, LDL; D016264:Dextran Sulfate